Short description
MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Description
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuously circulated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body.
MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.
Total funding
$$3123123
Sign in for full access
Location
London, England, United Kingdom, Europe
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Blurry Noaccess, Cannot Access, Nopepepe, Noaccess, Noaccess, No Way, Noway Youcantaccess, Noaccess, Blurry Noaccess, No Way, Blurry Noaccess
Sign in for full access
Founders
George Frodsham, Quentin Pankhurst